AKSTON BIOSCIENCES CORPORATION

Organization

BEVERLY, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 11,919,935
- Issue date Mar 5, 2024
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ultra-long acting insulin-Fc fusion protein and methods of use
- Patent number 11,814,418
- Issue date Nov 14, 2023
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 11,773,151
- Issue date Oct 3, 2023
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen specific immunotherapy for COVID-19 fusion proteins and met...
- Patent number 11,707,517
- Issue date Jul 25, 2023
- Akston Biosciences Corporation
- Todd C. Zion
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 11,673,934
- Issue date Jun 13, 2023
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Insulin-Fc fusion proteins and methods of use to treat cancer
- Patent number 11,667,689
- Issue date Jun 6, 2023
- Akston Biosciences Corporation
- Todd C. Zion
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cells engineered to express ultra-long acting insulin-Fc fusion pro...
- Patent number 11,555,058
- Issue date Jan 17, 2023
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Insulin-Fc fusions and methods of use
- Patent number 11,359,001
- Issue date Jun 14, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins
- Patent number 11,352,407
- Issue date Jun 7, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 11,267,862
- Issue date Mar 8, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 11,261,229
- Issue date Mar 1, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antigen specific immunotherapy for COVID-19 fusion proteins and met...
- Patent number 11,213,581
- Issue date Jan 4, 2022
- Akston Biosciences Corporation
- Todd C. Zion
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Ultra-long acting insulin-Fc fusion protein and methods of use
- Patent number 11,198,719
- Issue date Dec 14, 2021
- Akston Biosciences Corporation
- Todd C. Zion
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 10,961,294
- Issue date Mar 30, 2021
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 10,947,292
- Issue date Mar 16, 2021
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ultra-long acting insulin-FC fusion proteins and methods of use
- Patent number 10,870,686
- Issue date Dec 22, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ultra-long acting insulin-Fc fusion proteins and methods of use
- Patent number 10,851,147
- Issue date Dec 1, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Insulin-Fc fusions and methods of use
- Patent number 10,597,435
- Issue date Mar 24, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20240182539
- Publication date Jun 6, 2024
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20240101635
- Publication date Mar 28, 2024
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE
- Publication number 20240101636
- Publication date Mar 28, 2024
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND MET...
- Publication number 20240016921
- Publication date Jan 18, 2024
- Akston Biosciences Corporation
- Todd C. Zion
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER
- Publication number 20230272031
- Publication date Aug 31, 2023
- Akston Biosciences Corporation
- Todd C. Zion
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20230250148
- Publication date Aug 10, 2023
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER
- Publication number 20230072260
- Publication date Mar 9, 2023
- Akston Biosciences Corporation
- Todd C. Zion
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN
- Publication number 20220098266
- Publication date Mar 31, 2022
- Akston Biosciences Corporation
- Todd C. Zion
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND MET...
- Publication number 20220088182
- Publication date Mar 24, 2022
- Akston Biosciences Corporation
- Todd C. Zion
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20220064250
- Publication date Mar 3, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20220064251
- Publication date Mar 3, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE
- Publication number 20220056098
- Publication date Feb 24, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20220017590
- Publication date Jan 20, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20220009990
- Publication date Jan 13, 2022
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND MET...
- Publication number 20210346490
- Publication date Nov 11, 2021
- Akston Biosciences Corporation
- Todd C. Zion
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE
- Publication number 20210340212
- Publication date Nov 4, 2021
- Akston Biosciences Corporation
- Todd C. Zion
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE
- Publication number 20210324033
- Publication date Oct 21, 2021
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20210309709
- Publication date Oct 7, 2021
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20210300983
- Publication date Sep 30, 2021
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20200407414
- Publication date Dec 31, 2020
- Akston Biosciences Corporation
- THOMAS M. LANCATER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20200407413
- Publication date Dec 31, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20200231646
- Publication date Jul 23, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20200157170
- Publication date May 21, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20200157169
- Publication date May 21, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE
- Publication number 20200157171
- Publication date May 21, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INSULIN-FC FUSIONS AND METHODS OF USE
- Publication number 20200131243
- Publication date Apr 30, 2020
- Akston Biosciences Corporation
- Thomas M. Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INSULIN-FC FUSIONS AND METHODS OF USE
- Publication number 20190315828
- Publication date Oct 17, 2019
- Akston Biosciences Corporation
- Thomas M. Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
97762199 - AMBIFECT
- Serial number 97762199
- Registration number 7299268
- Filing date Jan 20, 2023
- Akston Biosciences Corporation
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88862625 - ANTICOV-ID
- Serial number 88862625
- Filing date Apr 7, 2020
- Akston Biosciences Corporation
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87812074 - HEBDOLIN
- Serial number 87812074
- Registration number 6653913
- Filing date Feb 27, 2018
- Akston Biosciences Corporation
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 6

Research Projects

Information Research Project
IND-enabling assay validation and toxicology studies on AKS-107: a...
- Application id 9964780
- Award notice date May 27, 2020
Information Research Project
IND-enabling assay validation and toxicology studies on AKS-107: a...
- Application id 9847198
- Award notice date Jun 25, 2019
Information Research Project
Selective Depletion of Insulin-Specific B cells to Prevent Type 1 D...
- Application id 9428441
- Award notice date Feb 16, 2018
Information Research Project
Selective Depletion of Insulin-Specific B cells to Prevent Type 1 D...
- Application id 9255832
- Award notice date Feb 8, 2017
Information Research Project
Selective Removal of Insulin-Specific B-cells to Prevent Type I Dia...
- Application id 8981050
- Award notice date Sep 10, 2015
Information Research Project
Novel Compounds for Reducing Brain A-Beta Levels via Enhanced Syste...
- Application id 8714773
- Award notice date Jun 14, 2014

AKSTON BIOSCIENCES CORPORATION

Organization

Patents Grantslast 30 patents

Ultra-long acting insulin-Fc fusion proteins and methods of use

Ultra-long acting insulin-Fc fusion protein and methods of use

Ultra-long acting insulin-Fc fusion proteins and methods of use

Antigen specific immunotherapy for COVID-19 fusion proteins and met...

Ultra-long acting insulin-Fc fusion proteins and methods of use

Insulin-Fc fusion proteins and methods of use to treat cancer

Cells engineered to express ultra-long acting insulin-Fc fusion pro...

Insulin-Fc fusions and methods of use

Ultra-long acting insulin-Fc fusion proteins

Ultra-long acting insulin-Fc fusion proteins and methods of use

Ultra-long acting insulin-Fc fusion proteins and methods of use

Antigen specific immunotherapy for COVID-19 fusion proteins and met...

Ultra-long acting insulin-Fc fusion protein and methods of use

Ultra-long acting insulin-Fc fusion proteins and methods of use

Ultra-long acting insulin-Fc fusion proteins and methods of use

Ultra-long acting insulin-FC fusion proteins and methods of use

Ultra-long acting insulin-Fc fusion proteins and methods of use

Insulin-Fc fusions and methods of use

Patents Applicationslast 30 patents

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND MET...

INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

INSULIN-FC FUSION PROTEINS AND METHODS OF USE TO TREAT CANCER

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND MET...

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND MET...

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEIN AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

INSULIN-FC FUSIONS AND METHODS OF USE

INSULIN-FC FUSIONS AND METHODS OF USE

Trademarklast 30 trademarks

97762199 - AMBIFECT

88862625 - ANTICOV-ID

87812074 - HEBDOLIN

NIH Research Projectlast 12 months

Research Projects

IND-enabling assay validation and toxicology studies on AKS-107: a...

IND-enabling assay validation and toxicology studies on AKS-107: a...

Selective Depletion of Insulin-Specific B cells to Prevent Type 1 D...

Selective Depletion of Insulin-Specific B cells to Prevent Type 1 D...

Selective Removal of Insulin-Specific B-cells to Prevent Type I Dia...

Novel Compounds for Reducing Brain A-Beta Levels via Enhanced Syste...